Navigation Links
Genetic predisposition increases childhood asthma risk
Date:8/20/2007

Children who carry variations in specific genes that metabolize vehicle emissions are more susceptible to developing asthma, particularly if they live near major roadways, a study led by researchers at the University of Southern California (USC) suggests.

Researchers found that children who carried variations in two genes and lived within 75 meters of a major road were up to nine times more likely to develop asthma than children who lived further away, says Muhammad T. Salam, Ph.D. candidate at the Keck School of Medicine of USC, and the studys lead author. The study will appear in the journal Thorax, and is now available online.

This is one of the first studies to report that children with certain genetic backgrounds are even more susceptible to asthma than if they lived near major roads and did not carry the variations, Salam says. We are working to understand how traffic-related exposures may interact with these genes, leading to asthma development.

Asthma is the most common chronic disease in children, and previous studies have shown that traffic-related pollution near the home increases asthma risk and reduces lung growth, according to USC experts.

Researchers drew upon data from the Childrens Health Study (CHS), a longitudinal study of respiratory health among school-age children in 12 Southern California communities. They compared associations between number of genetic variants and exposure to toxins among more than 3,000 study participants.

Researchers found that high levels of microsomal epoxide hydrolase (EPHX1)an enzyme that metabolizes polyaromatic hydrocarbons (PAH) in vehicle emissionswas associated with an increased risk for lifetime asthma. Children with high EPHX1 levels who also carried variations in glutathione S-transferase P1 (GSTP1) genes were four times more likely to have asthma.

Among children who lived within 75 meters of a major road, those with high EPHX1 activity were three times more likely to have asthma than those with lower activity. Children who carried both variations and lived within 75 meters of a major road were at the highest asthma risk. The results were consistent for current, early and late onset asthma.

"This finding demonstrates the critical role of gene environment interaction in determining disease susceptibility," says David A. Schwartz, M.D., director of the National Institute of Environmental Health Sciences. "The investigators at USC have identified key genetic variations in biological pathways related to PAH metabolism that are associated with the occurrence of asthma in children who live in close proximity to traffic."

Approximately 12 percent of children in the study carried both of the variations and three percent were in the highest risk group based on where they lived. However, there are a number of genes that could be linked with asthma, and researchers are just beginning to study the associations between genes and environmental factors, Salam says.

It is difficult to say that if parents with an asthmatic child move further from busy streets, the child will definitely have fewer symptoms, he explains. All that can be said at this moment is that data from this and other studies show strong evidence that living near heavy traffic increases asthma risks and exacerbates symptoms in children who already have asthma.


'/>"/>
Contact: Meghan Lewit
lewit@usc.edu
323-442-2830
University of Southern California
Source:Eurekalert

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Crowning glory of 2000!!! Cracking of the genetic code is top of tops
3. Genetic influence in menopause
4. Genetics and cholesterol levels
5. Genetics helps in attacking cancer
6. DNA biochip for genetic screening
7. Genetic disorder related with sleep patterns
8. Genetic innovation
9. Sleepwalking has genetic roots
10. A new genetic label for stroke
11. Genetic tests for cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: